VOGLISUG-RAPID TAB
| Brand | VOGLISUG-RAPID TAB |
|---|---|
| Composition | Repaglinide 1mg + Voglibose 0.3mg |
| Packing | 10 x 10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about VOGLISUG-RAPID TABIndication
Management of type 2 diabetes mellitus in adults requiring combination therapy, alongside diet and exercise.
Mechanism of action
Repaglinide stimulates insulin release from functioning pancreatic beta cells. Voglibose inhibits intestinal alpha-glucosidase enzymes, delaying carbohydrate digestion and glucose absorption.
For pharmaceutical trade information, not a patient-specific prescription. Use the current approved product insert and the prescribing clinician's directions.
VOGLISUG-RAPID TAB for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
VOGLISUG-GM 3Voglibose 0.3mg + Glimepiride 2mg+ Metformin HCI 500mg
VOGLISUG-GM-2/1000 TABSVoglibose 0.2mg + Glimepiride 2mg + Metformin HCL 1000
VOGLISUG-GM-1/1000 TABSVoglibose 0.1mg + Glimepiride 1mg + Metformin HCL 1000
VOGLISUG-TRIO 0.3 TabletsGliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg